Performance of Safety of SILKAM® Suture Material in Oral Surgery
SILKOS
Single Center Open-Label Post Market Clinical Follow-Up (PMCF) -Study on the Performance of Safety of SILKAM® Suture Material in Oral Surgery
1 other identifier
observational
105
1 country
1
Brief Summary
Assessment of SILKAM® suture material in mucosal closure in oral surgery (mucosal sutures). A prospective, monocentric, single arm observational study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2022
CompletedFirst Posted
Study publicly available on registry
March 25, 2022
CompletedStudy Start
First participant enrolled
September 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2023
CompletedFebruary 20, 2024
February 1, 2024
1.1 years
March 16, 2022
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Surgical Wound Dehiscence rate
Pathologic process consisting of a partial or complete disruption of the layers of a surgical wound.
until day of suture removal (approximately 1 week after surgery)
Complication rate
Complications rate according to the "Classification of Askar" as Grade 1 (Localized complication(s) accompanied by no adverse effects on the success of the surgery) and Grade 2 (Localized complication(s) accompanied by adverse effects on the success of the surgery).
until day of suture removal (approximately 1 week after surgery)
Secondary Outcomes (5)
Complication rate
until day of suture removal (approximately 1 week after surgery)
Pain assessment using the visual analogue scale (VAS 1-100)
until day of suture removal (approximately 1 week after surgery)
Satisfaction of the patient using the visual analogue scale (VAS 1-100)
until day of suture removal (approximately 1 week after surgery)
Wound healing assessment using the visual analogue scale (VAS 1-100)
until day of suture removal (approximately 1 week after surgery)
Assessment of the handling of the suture material
intraoperatively
Study Arms (1)
SILKAM®
SILKAM® is a non-absorbable sterile suture material made from braided silk fibrils. It is available either undyed (white) or dyed black with hematein and is coated with refined paraffin wax or beeswax.
Interventions
Eligibility Criteria
Adult patients undergoing mucosal closure in oral surgery (mucosal sutures).
You may qualify if:
- Patients undergoing mucosal wound closure using SILKAM® as suture material in oral surgery (in the event that more than one incision is performed in the same patient, only one incision will be considered).
You may not qualify if:
- Patients taking medication that might affect wound healing
- Patients having a condition that might affect wound healing.
- Patients with hypersensitivity or allergy to the suture material.
- Participation in another (Randomized) Clinical Trial / Clinical Study.
- Non-compliance of patient (i.e. dementia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aesculap AGlead
- B.Braun Surgical SAcollaborator
Study Sites (1)
Facultat D'odontologia. Universitat Internacional de Catalunya
Sant Cugat del Vallès, Catalonia, 08195, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Quevedo Pou, Dr.
Facultat D'odontologia. Universitat Internacional de Catalunya
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2022
First Posted
March 25, 2022
Study Start
September 21, 2022
Primary Completion
October 21, 2023
Study Completion
November 16, 2023
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share